<SEC-DOCUMENT>0001104659-17-044077.txt : 20170707
<SEC-HEADER>0001104659-17-044077.hdr.sgml : 20170707
<ACCEPTANCE-DATETIME>20170707161512
ACCESSION NUMBER:		0001104659-17-044077
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170629
FILED AS OF DATE:		20170707
DATE AS OF CHANGE:		20170707

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Voyager Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001640266
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		75 SIDNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-259-5340

	MAIL ADDRESS:	
		STREET 1:		75 SIDNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ravina Bernard
		CENTRAL INDEX KEY:			0001711276

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37625
		FILM NUMBER:		17955382

	MAIL ADDRESS:	
		STREET 1:		C/O VOYAGER THERAPEUTICS, INC.
		STREET 2:		75 SIDNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>a3.xml
<DESCRIPTION>3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2017-06-29</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001640266</issuerCik>
        <issuerName>Voyager Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>VYGR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001711276</rptOwnerCik>
            <rptOwnerName>Ravina Bernard</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O VOYAGER THERAPEUTICS</rptOwnerStreet1>
            <rptOwnerStreet2>75 SIDNEY STREET</rptOwnerStreet2>
            <rptOwnerCity>CAMBRIDGE</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02139</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Medical Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>117647</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>7.2700</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2015-04-27</value>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2025-04-27</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>11364</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>8.3300</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2015-08-26</value>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2025-08-26</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>5882</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>11.0900</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2016-02-01</value>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2026-02-01</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>401</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>11.0900</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2016-02-01</value>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2026-02-01</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>24599</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>11.83</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2017-02-08</value>
                <footnoteId id="F5"/>
            </exerciseDate>
            <expirationDate>
                <value>2027-02-08</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>11942</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>11.83</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2017-02-08</value>
                <footnoteId id="F6"/>
            </exerciseDate>
            <expirationDate>
                <value>2027-02-08</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>53058</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">This option vests in 48 equal monthly installments, commencing on 04/27/2015, provided that, as of each such vesting date, Mr. Ravina continues to provide services to Voyager Therapeutics, Inc. (the &quot;Company&quot;).</footnote>
        <footnote id="F2">This option vests in 48 equal monthly installments, commencing on 08/26/2015, provided that, as of each such vesting date, Mr. Ravina continues to provide services to the Company.</footnote>
        <footnote id="F3">This option vests in 48 equal monthly installments, commencing on 02/01/2016 , provided that, as of each such vesting date, Mr. Ravina continues to provide services to the Company.</footnote>
        <footnote id="F4">This option vests in 48 equal monthly installments, commencing on 02/01/2016, provided that, as of each such vesting date, Mr. Ravina continues to provide services to the Company.</footnote>
        <footnote id="F5">This option vests in 48 equal monthly installments, commencing on 02/08/2017, provided that, as of each such vesting date, Mr. Ravina continues to provide services to the Company.</footnote>
        <footnote id="F6">This option vests in 48 equal monthly installments, commencing on 02/08/2017, provided that, as of each such vesting date, Mr. Ravina continues to provide services to the Company.</footnote>
    </footnotes>

    <remarks>Exhibit 24.1: Limited Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Shannyn Gaughan, As Attorney-in-Fact for Bernard Ravina</signatureName>
        <signatureDate>2017-07-03</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>ex-24d1.htm
<DESCRIPTION>EX-24.1
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 24.1</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">LIMITED POWER OF ATTORNEY</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned hereby constitutes and appoints each of Jane Henderson, Laurie Burlingame, Benjamin Piper and Shannyn Gaughan, signing singly, and with full power of substitution, the undersigned&#146;s true and lawful attorney-in-fact to:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.55in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; execute for and on behalf of the undersigned, in the undersigned&#146;s capacity as an officer and/or director of <b>Voyager Therapeutics,&nbsp;Inc.</b> (the &#147;Company&#148;), from time to time the following U.S. Securities and Exchange Commission (&#147;SEC&#148;) forms: (i)&nbsp;Form&nbsp;ID, including any attached documents, to effect the assignment of codes to the undersigned to be used in the transmission of information to the SEC using the EDGAR System; (ii)&nbsp;Form&nbsp;3,&nbsp;Initial Statement of Beneficial Ownership of Securities, including any attached documents; (iii)&nbsp;Form&nbsp;4, Statement of Changes in Beneficial Ownership of Securities, including any attached documents; (iv)&nbsp;Form&nbsp;5, Annual Statement of Beneficial Ownership of Securities in accordance with Section&nbsp;16(a)&nbsp;of the Securities Exchange Act of 1934, as amended, and the rules&nbsp;thereunder, including any attached documents; (v)&nbsp;Schedule 13D; (vi)&nbsp;Schedule 13G; and (vii)&nbsp;amendments of each thereof, in accordance with the Securities Exchange Act of 1934, as amended, and the rules&nbsp;thereunder, including any attached documents;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.55in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; do<font size="1" style="font-size:8.0pt;">  </font>and<font size="1" style="font-size:8.0pt;">  </font>perform<font size="1" style="font-size:8.0pt;">  </font>any<font size="1" style="font-size:8.0pt;">  </font>and<font size="1" style="font-size:8.0pt;">  </font>all<font size="1" style="font-size:8.0pt;">  </font>acts<font size="1" style="font-size:8.0pt;">  </font>for<font size="1" style="font-size:8.0pt;">  </font>and<font size="1" style="font-size:8.0pt;">  </font>on<font size="1" style="font-size:8.0pt;">  </font>behalf<font size="1" style="font-size:8.0pt;">  </font>of<font size="1" style="font-size:8.0pt;">  </font>the<font size="1" style="font-size:8.0pt;">  </font>undersigned<font size="1" style="font-size:8.0pt;">  </font>which<font size="1" style="font-size:8.0pt;">  </font>may<font size="1" style="font-size:8.0pt;">  </font>be<font size="1" style="font-size:8.0pt;">  </font>necessary<font size="1" style="font-size:8.0pt;">  </font>or<font size="1" style="font-size:8.0pt;">  </font>desirable<font size="1" style="font-size:8.0pt;">  </font>to<font size="1" style="font-size:8.0pt;">  </font>complete<font size="1" style="font-size:8.0pt;">  </font>and<font size="1" style="font-size:8.0pt;">  </font>execute<font size="1" style="font-size:8.0pt;">  </font>any<font size="1" style="font-size:8.0pt;">  </font>such<font size="1" style="font-size:8.0pt;">  </font>Form<font size="1" style="font-size:8.0pt;">  </font>3,<font size="1" style="font-size:8.0pt;">  </font>4<font size="1" style="font-size:8.0pt;">  </font>or<font size="1" style="font-size:8.0pt;">  </font>5,<font size="1" style="font-size:8.0pt;">  </font>Schedule<font size="1" style="font-size:8.0pt;">  </font>13D,<font size="1" style="font-size:8.0pt;">  </font>Schedule<font size="1" style="font-size:8.0pt;">  </font>13G<font size="1" style="font-size:8.0pt;">  </font>or<font size="1" style="font-size:8.0pt;">  </font>any<font size="1" style="font-size:8.0pt;">  </font>amendment(s)<font size="1" style="font-size:8.0pt;">  </font>thereto,<font size="1" style="font-size:8.0pt;">  </font>and<font size="1" style="font-size:8.0pt;">  </font>timely<font size="1" style="font-size:8.0pt;">  </font>file<font size="1" style="font-size:8.0pt;">  </font>such<font size="1" style="font-size:8.0pt;">  </font>form(s)<font size="1" style="font-size:8.0pt;">  </font>with<font size="1" style="font-size:8.0pt;">  </font>the<font size="1" style="font-size:8.0pt;">  </font>SEC<font size="1" style="font-size:8.0pt;">  </font>and<font size="1" style="font-size:8.0pt;">  </font>any<font size="1" style="font-size:8.0pt;">  </font>securities<font size="1" style="font-size:8.0pt;">  </font>exchange,<font size="1" style="font-size:8.0pt;">  </font>national<font size="1" style="font-size:8.0pt;">  </font>association<font size="1" style="font-size:8.0pt;">  </font>or<font size="1" style="font-size:8.0pt;">  </font>similar<font size="1" style="font-size:8.0pt;">  </font>authority;<font size="1" style="font-size:8.0pt;">  </font>and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.55in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact&#146;s discretion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned hereby grants to each such attorney-in-fact, acting singly, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact&#146;s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned&#146;s responsibilities to comply with Section&nbsp;16 or Regulation 13D-G of the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees to indemnify the attorney-in-fact and the Company from and against any demand, damage, loss, cost or expense arising from any false or misleading information provided by the undersigned to the attorney-in-fact.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.45in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such forms with respect to the undersigned&#146;s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney supersedes any prior power of attorney in connection with the undersigned&#146;s capacity as an officer and/or director of the Company. This Power of Attorney shall expire as to any individual attorney-in-fact if such attorney-in-fact ceases to be an executive officer of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.45in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN </font>WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of June&nbsp;30, 2017.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Bernard Ravina, </font>M.D.</p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bernard Ravina, </font>M.D.</p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\C902421\17-15980-9\task8495469\15980-9-km.htm',USER='C902421',CD='Jul  7 10:09 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
